| For: | Zhang JW. Role of 1,25-dihydroxyvitamin D3 in alleviating hepatic steatosis: Targeting M1 macrophage polarization in non-alcoholic fatty liver disease. World J Gastrointest Oncol 2025; 17(3): 102424 [PMID: 40092934 DOI: 10.4251/wjgo.v17.i3.102424] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i3/102424.htm |
| Number | Citing Articles |
| 1 |
Mingxia Gao, Chuan Lin, Yanhua Li, Ling Li, Xiaoqiao Chen, Jing Wang, Wenhua Du, Qing Pan. Glucose metabolic dysfunction surpasses dyslipidemia in driving hepatic steatosis and fibrosis: evidence from a nationally representative population. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01945-9
|
| 2 |
Gang Ma, Chongxiao Li, Erzhuo Xia, Jingbo Wang, Ying Han. Serum vitamin D and lean non-alcoholic fatty liver disease: a nonlinear ‘L-shaped’ association in a national cross-sectional study. Annals of Medicine 2026; 58(1) doi: 10.1080/07853890.2026.2634463
|
